Black Rock Inc. Invo Bioscience, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.64 - $2.66 $15,754 - $65,478	-24,616 Reduced 98.15%	463 $0
Q1 2022 May 12, 2022	SELL	$2.19 - $3.82 $2,680 - $4,675	-1,224 Reduced 4.65%	25,079 $66,000
Q4 2021 Feb 10, 2022	BUY	$2.93 - $4.19 $3,348 - $4,789	1,143 Added 4.54%	26,303 $88,000
Q3 2021 Nov 09, 2021	BUY	$3.17 - $4.61 $9,510 - $13,830	3,000 Added 13.54%	25,160 $82,000
Q2 2021 Aug 11, 2021	BUY	$3.71 - $5.18 $82,213 - $114,788	22,160 New	22,160 $103,000

14.1K

Ticker INVO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,169,700
Market Cap $9.86M
Description
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.